Drug recall · April 19, 2017
Doxercalciferol Capsules 0.5mcg recall
Why: Failed Tablet/Capsule Specifications; during an internal inspection, capsules were found with illegible print.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Doxercalciferol Capsules 0.5mcg, 50 count bottles, Rx, only, Manufactured by Cipla Limited Kurkumbh, Maharashtra, India, Manufactured for West-Ward, Pharmaceuticals, Corp., Eatontown, NJ -- NDC 0054-0338-19
- Lots / codes
Lot KB60707, 10/31/2018
- Quantity
- 100 bottles
- Company
- West-Ward Columbus, Inc., Columbus, OH
- Distribution
- The recalled product was distributed to the following state: OH. There are no Canada accounts for this recall. There are no Mexico accounts for this recall. There are no government accounts for this recall.
- Initiated
- April 4, 2017 · Voluntary: Firm initiated
- Classified
- April 7, 2017
- Reported
- April 19, 2017
- Ended
- September 4, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Doxercalciferol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.